Anti-cancer peptides: classification, mechanism of action, reconstruction and modification.

Xie, Mingfeng et al.·Open biology·2020·
RPEP-052062020RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Anti-cancer peptides: classification, mechanism of action, reconstruction and modification.
Published In:
Open biology, 10(7), 200004 (2020)
Database ID:
RPEP-05206

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-05206·https://rethinkpeptides.com/research/RPEP-05206

APA

Xie, Mingfeng; Liu, Dijia; Yang, Yufeng. (2020). Anti-cancer peptides: classification, mechanism of action, reconstruction and modification.. Open biology, 10(7), 200004. https://doi.org/10.1098/rsob.200004

MLA

Xie, Mingfeng, et al. "Anti-cancer peptides: classification, mechanism of action, reconstruction and modification.." Open biology, 2020. https://doi.org/10.1098/rsob.200004

RethinkPeptides

RethinkPeptides Research Database. "Anti-cancer peptides: classification, mechanism of action, r..." RPEP-05206. Retrieved from https://rethinkpeptides.com/research/xie-2020-anticancer-peptides-classification-mechanism

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.